International Journal of Pharma Insight Studies
Duties of Reviewers
At IJPIS, the peer review process plays a crucial role in maintaining the integrity, rigor, and quality of the scientific research we publish. Reviewers serve as key contributors, assisting editors in making informed editorial decisions and helping authors enhance the quality of their manuscripts through constructive feedback. As peer review is fundamental to scholarly communication, we expect our reviewers to uphold the highest standards of professionalism and objectivity.
Contribution to Editorial Decisions
Reviewers' assessments provide critical insights that support editorial decisions. Through effective communication with authors, reviewers help ensure that manuscripts meet the journal’s high standards. At International Journal of Pharma Insight Studies, we believe that all scholars engaged in the scientific process have a responsibility to contribute meaningfully to peer review.
Promptness
Reviewers are expected to complete their evaluations within the agreed-upon time frame. If a reviewer feels unqualified to assess a manuscript or anticipates a delay, they should promptly inform the editorial team, allowing alternative reviewers to be assigned.
Confidentiality
Manuscripts under review are confidential documents and must be treated as such. Reviewers should not share, disclose, or discuss the content with others, except when explicitly authorized by the Editor-in-Chief. This confidentiality applies even to reviewers who decline an invitation to review.
Standards of Objectivity
Reviews must be conducted impartially, with observations supported by clear arguments. Personal criticism of the authors is unacceptable. Constructive and specific feedback enables authors to improve their work, ultimately enhancing the quality of the research published in IJPIS.
Acknowledgement of Sources
Reviewers should ensure that any relevant work not cited by the authors is acknowledged, and any substantial similarity between the manuscript under review and other published or unpublished work should be reported to the editors.
Disclosure and Conflicts of Interest
Reviewers must notify the editors of any conflicts of interest that could influence their objectivity. This includes competitive, collaborative, or other relationships with the authors, companies, or institutions associated with the manuscript. Any unpublished material disclosed in the review process must not be used in a reviewer’s own research without the express written consent of the authors. Privileged information obtained through peer review must remain confidential and must not be used for personal advantage.
International Journal of Pharma Insight Studies values the dedication of its reviewers in upholding the integrity of scientific research and maintaining the journal’s commitment to excellence.